nCounter® Vantage 3D Grant Program Application

The nCounter Vantage 3D Assays enable simultaneous detection of DNA, RNA, and protein changes in a single assay to use less precious material and gather more informative data. Based on the proven nCounter digital molecular barcoding technology, this approach removes potential bias amplification and simplifies analysis by comparing genotype and gene and protein expression in a single view. For product information, configurations, and lists of targets, visit Immune Assays and Solid Tumor Assays.

Now Accepting Applications

We are thrilled to announce that we are a winner for The Scientist Top 10 Innovations 2016 Award

Grant Program
























Which content will support your proposal (select one combination that includes DNA, RNA, and Protein)*


DNA SNV Solid Tumor Panel
DNA: Fusion Lung Assay


nCounter Vantage 3D RNA Panel


RNA:Protein Immune Cell Profiling Assay for cell suspensions
Protein Immune Cell Profiling Assay for cell suspensions
RNA:Protein Immune Cell Signaling Assay for cell suspensions
Protein Immune Cell Signaling Assay for cell suspensions
RNA:Protein Solid Tumor Assay for lysate
Protein Solid Tumor Assay for lysate
RNA:Protein Solid Tumor Assay for FFPE
Protein Solid Tumor Assay for FFPE






Grant Program Details

Application Deadline: January 31, 2017

Grant Recipient Notification: February 15, 2017

Description: Please submit the following:

Award: Four submissions will be awarded reagents selected above to profile 36 samples using their desired nCounter Vantage 3D Assays. Winning submissions will be selected by NanoString in its sole discretion.

Award Shipment Date: This panel will be shipped in 2017.

Restrictions: M.D.s are not eligible to apply for this grant.

Terms & Conditions: By submitting your application, you agree that NanoString may use your name, abstract title, abstract and your submitted quote for marketing purposes.





FOR RESEARCH USE ONLY. Not for use in diagnostic procedures.